Picture of Taisho Pharmaceutical Holdings Co logo

4581 — Taisho Pharmaceutical Holdings Co News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Table: Taisho Pharmaceutical HD -2018/19 group results

May 13 (Reuters)- 
          Taisho Pharmaceutical Holdings Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to       NEXT   
                Mar 31, 2019    Mar 31, 2018   Mar 31, 2020     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales            261.55          280.09         253.50        126.50   
                 (-6.6 pct)      (+0.1 pct)     (-3.1 pct)    (-2.3 pct) 
  Operating         31.21           36.98          35.50         16.50   
                 (-15.6 pct)     (+15.7 pct)    (+13.7 pct)   (-2.9 pct) 
  Recurring         40.85           42.14          42.50         20.00   
                 (-3.1 pct)      (+10.8 pct)    (+4.0 pct)   (-11.9 pct) 
  Net
  Net               48.59           31.68          28.50         13.50   
                 (+53.4 pct)     (+10.1 pct)    (-41.4 pct)  (-68.2 pct) 
  EPS            608.80 yen      396.54 yen     357.11 yen    169.15 yen 
  EPS Diluted    608.22 yen      396.20 yen                              
  Ann Div        120.00 yen      110.00 yen     110.00 yen               
  -Q2 Div         50.00 yen       50.00 yen      50.00 yen               
  -Q4 Div         70.00 yen       60.00 yen      60.00 yen               
  
  NOTE - Taisho Pharmaceutical Holdings Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4581.T

Recent news on Taisho Pharmaceutical Holdings Co

See all news